Kyverna Therapeutics, Inc. Quarterly Interest Expense in USD from Q1 2023 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of the cost of borrowed funds accounted for as interest expense.
Summary: Kyverna Therapeutics, Inc. quarterly Interest Expense history and growth rate from Q1 2023 to Q2 2024.
Kyverna Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $39K, a 15.2% decline year-over-year.

Interest Expense, Quarterly (USD)

Interest Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024		$39K	-$7K	-15.2%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-12
Q1 2024		$44K	$0	0%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-14
Q2 2023		$46K			Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-12
Q1 2023		$44K			Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.